Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Captivision Announces Additional Extensions Granted by Nasdaq and Receipt of Additional Determination Letter; Extension Enables Audit Completion to Regain Compliance and Strategic Acquisition to creat
-
OSS Announces New Partnership with Leading U.S. Defense Prime to Develop Enhanced Integrated Vision System for U.S. Army
-
BGB Group Acquires Hayden Consulting Group to Bolster Market Access and Patient Services
-
Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards
-
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
-
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
-
Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
-
Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference
-
CALIFORNIA BANCORP ANNOUNCES RETIREMENT OF CEO STEVEN SHELTON AND APPOINTMENT OF DAVID RAINER AS CEO
-
Fulcrum Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
-
Freshworks Appoints Kady Srinivasan as Chief Marketing Officer
-
Form 8.3 - [IDOX PLC - 06 01 2026] - (CGWL)
-
Artios to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
-
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
-
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
-
Form 8.3 - [IQE PLC - 06 01 2026] - (CGAML)
-
Form 8.3 - [IDOX PLC - 06 01 2026] - (CGAML)
-
Form 8.3 - Inspecs Group Plc
-
KLC ALERT: Shareholder Justice Law Firm Julie & Holleman LLP Is Investigating KinderCare’s Directors and Officers for Potential Wrongdoing
-
XPO Renews Support for Susan G. Komen® 3-Day Walks as Official Transportation Partner
-
Form 8.3 - Frenkel Topping Group Plc
-
Form 8.3 - 1Spatial Plc
-
Capital Power extends its Arlington Valley tolling agreement to 2038 and increases its summer capacity by 35 MWs, enhancing reliability and long-term value
-
FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum
-
BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™
-
Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Palvella Therapeutics Strengthens Leadership Team with Appointment of Veteran Medical Affairs Leader Vimal Patel, PharmD, as Senior Vice President of Medical Affairs
-
TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Hypercharge Announces Hypercorp Energy Solutions to Orchestrate the Future of Energy Management
-
Creative Realities Launches Digital Drive-Thru 2.0, a Modular, Scalable Solution Designed to Improve Drive-Thru Efficiency and Flexibility
-
Anterix Appoints Ross Spero as Chief Product Officer
-
Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
-
Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Social Media Influence in the Exam Room: National Survey About Medical Testing Reveals Changing Patient Expectations
-
Stardust Power Engages 38 North Solutions To Support Federal Government Relations
-
FreshBooks and Kick Bring Self-Driving Bookkeeping to U.S. Small Businesses
-
TappAlpha and Tuttle Capital Launch the T² Lift™ Series with TSYX and TDAX — Light-Leverage Versions of TSPY and TDAQ Designed to Offer 30% More Exposure to Growth + Income
-
Digital Currency X Technology Expands Digital Asset Strategy Through Token Staking with EdgeAI Foundation
-
Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy
-
Paul Hollis Confirmed as 41st Director of the United States Mint
-
Kraig Biocraft Laboratories Takes Possession of Three Strategic Mulberry Fields Advancing Massive Spider Silk Production Ramp-Up
-
Oroco Announces Bought Deal Financing Led by Canaccord Genuity
-
Clarios Launches Trailer Battery Manager to Expand Connected Services Platform
-
First Diamond Drill Program Commences at Nobel’s Flagship Cuprita Copper Project, Antofagasta Region, Chile
-
Automotive Industry Veteran Jacob Tilzer and Accrual Equity Partners Launch Gemba Automotive in Arizona
-
Emerita Intersects 2.1m Grading 1.6% Copper, 0.85 g/t Gold, 32.11 g/t Silver and 1.4m Grading 5.8% Copper, 4.89 g/t Gold and 51.0 g/t Silver at El Cura
-
Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects
